tried to address the failings of the nation's medical system directly by passing health-care reform legislation earlier this year. They provoked a powerful political backlash that contributed to last week's electoral defeats.
Unlike almost any other area of government investment, the public accepts that benefits from basic research are unpredictable and long term. Politicians thus get to fob off accountability on the scientific community, whose only responsibility is to ensure that funding goes to the 'best' science. It's no surprise, then, that in many ways the NIH and NSF are the government's crown jewels, extolled by Republicans and Democrats alike because they give away billions of dollars to scientists efficiently, transparently and with minimal scandal or controversy.
So, doubling the NSF budget makes good politics. But what about good policy? Although few would question the value of a robust basic-science enterprise, we just don't know how marginal increases in basicresearch funding affect a nation's capacity to solve social and economic problems. On the other hand, decades of research on the links between science and innovation in areas ranging from jet engines to medicines show that basic research best contributes to economic and social goals when targeted at areas that can directly benefit from additional fundamental knowledge. If Congress wanted to allocate scarce new R&D resources wisely during a protracted period of budgetary austerity, it wouldn't adopt a doubling strategy, but would instead take a more surgical approach to set priorities. It would focus investments where links between science and application are well established, to deliver short-to medium-term benefits. Alternative energy, for example, offers many technological options where basic research can improve performance. And if Congress is going to cut R&D, it could look towards research areas that, despite huge, long-term investment, have shown weak links to desired social outcomes. Much basic research on cancer and on climate change fall into this category.
I know that such an approach would be fiercely opposed by the leading voices of the scientific community, who will never abandon the long-falsified belief that basic research is most valuable to society as a bottom-up enterprise driven only by inherent scientific interest. More over, the political attractiveness of generic basic research funded by agencies such as the NSF could be one of the few things that Republicans and Democrats agree on in the next two years. But we shouldn't fool ourselves into thinking that the most politically expedient way to support science is also the most socially beneficial. GooD PoLItIcS.
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